Finance

Lists
Why is KVUE up 3,66%?
Dive Deeper
KVUE:NYSE
Kenvue Inc
18,67 $
+3,66%
(+0,66) 1D
18,64 $
-0,16% (-0,030)
After hours
Closed: 15 հոկ, 16:00:04 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for KVUE...
Open
18,38 $
High
18,77 $
Low
18,38 $
Mkt. cap
35,86 մլրդ
Avg. vol.
24,40 մլն
Volume
26,38 մլն
Dividend
4,50%
Quarterly dividend
0,21 $
Ex-dividend date
21 սեպ, 2026 թ.
P/E ratio
21,65
52-wk high
20,13 $
52-wk low
14,02 $
EPS
0,86 $
Beta
0,48
Shares outstanding
1,92 մլրդ
No. of employees
22 հզր
Open
18,38 $
High
18,77 $
Low
18,38 $
Mkt. cap
35,86 մլրդ
Avg. vol.
24,40 մլն
Volume
26,38 մլն
Dividend
4,50%
Quarterly dividend
0,21 $
Ex-dividend date
21 սեպ, 2026 թ.
P/E ratio
21,65
52-wk high
20,13 $
52-wk low
14,02 $
EPS
0,86 $
Beta
0,48
Shares outstanding
1,92 մլրդ
No. of employees
22 հզր
News stories
From web sources and news partners
Profile
Kenvue Inc. is an American consumer health company. Formerly the Consumer Healthcare division of Johnson & Johnson, Kenvue owns well-known brands such as Aveeno, Band-Aid, Benadryl, Zyrtec, Johnson's, Listerine, Lactaid, Mylanta, Neutrogena, Trosyd, Calpol, Tylenol, and Visine. Kenvue is incorporated in Delaware and was originally headquartered in the Skillman section of Montgomery Township, New Jersey, before relocating to Summit, New Jersey. Johnson & Johnson announced in November 2021 that it would spin off its consumer health division as a separate company. The new company was named Kenvue in September 2022, and its initial public offering took place in May 2023, raising $3.8 billion in the largest U.S. IPO since 2021, with an initial valuation of about $41 billion. Johnson & Johnson initially retained more than 90% ownership before completing a full separation through a share exchange in July 2023. Kenvue was subsequently added to the S&P 500 Dividend Aristocrats index. CEO Thibaut Mongon initially led Kenvue, which employed about 22,200 people in 2022. Following Mongon’s termination in 2025, Kirk Perry was named interim CEO. Wikipedia
About Kenvue Inc
CEOKirk Perry
Employees21,9 հզր
Founded2022
HeadquartersSummit, Նյու Ջերսի, Միացյալ Նահանգներ
SectorPersonal care products
Websitekenvue.com
Analyst ratings
Based on 7 analysts giving stock ratings to KVUE in the past 3 months
Hold
Buy
1
Hold
6
Sell
0
12-month forecast
Based on 7 Wall Street analysts offering 12 month price targets for KVUE in the last 3 months.
Highest
Current 18,67 $
20,00 $ (+7,12%)
Average
19,25 $ (+3,11%)
Lowest
19,00 $ (+1,77%)
Analyst
Recommendation
Action
Price target
Projected
Date
Filippo Falorni
Citi
Hold
Maintained
19,00 $
+1,8%
10/14/2026
Susan Anderson
Canaccord Genuity
Buy
Maintained
-
-
09/16/2026
Taylor Conrad
Argus Research
Hold
Maintained
-
-
09/14/2026
Peter Grom
UBS
Hold
Maintained
19,00 $
+1,8%
08/11/2026
Nik Modi
RBC Capital
Hold
Maintained
20,00 $
+7,1%
08/07/2026
Jon Andersen
William Blair
Hold
Maintained
-
-
08/06/2026
Lauren Lieberman
Barclays
Hold
Maintained
19,00 $
+1,8%
08/06/2026
Javier Escalante
Evercore ISI
Hold
Maintained
18,00 $
-3,6%
02/18/2026
Keith Devas
Jefferies
Hold
Downgraded
18,00 $
-3,6%
01/30/2026
Last report
06 օգս, 2026 թ.
Fiscal period
Q2 2026
0,31 $ / 0,32 $
-2,82%miss
Revenue / Est. (USD)
3,96 մլրդ / 3,97 մլրդ
-0,36%miss
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
3,76 մլրդ
3,78 մլրդ
3,91 մլրդ
3,96 մլրդ
Cost of goods sold
1,53 մլրդ
1,63 մլրդ
1,60 մլրդ
1,64 մլրդ
Cost of revenue
1,53 մլրդ
1,63 մլրդ
1,60 մլրդ
1,64 մլրդ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,51 մլրդ
1,51 մլրդ
1,45 մլրդ
1,54 մլրդ
Operating expense
1,51 մլրդ
1,48 մլրդ
1,46 մլրդ
1,54 մլրդ
Total operating expenses
3,04 մլրդ
3,11 մլրդ
3,06 մլրդ
3,19 մլրդ
Operating income
726,00 մլն
674,00 մլն
845,00 մլն
768,00 մլն
Other non operating income
10,00 մլն
7,00 մլն
-
1,00 մլն
EBT including unusual items
526,00 մլն
427,00 մլն
672,00 մլն
598,00 մլն
EBT excluding unusual items
623,00 մլն
574,00 մլն
750,00 մլն
667,00 մլն
Income tax expense
128,00 մլն
97,00 մլն
198,00 մլն
142,00 մլն
Effective tax rate
24,33%
22,72%
29,46%
23,75%
Other operating expenses
1,00 մլն
-30,00 մլն
11,00 մլն
6,00 մլն
Net income
398,00 մլն
330,00 մլն
474,00 մլն
456,00 մլն
Net profit margin
10,57%
8,73%
12,13%
11,53%
Earnings per share
0,28
0,27
0,32
0,31
Interest and investment income
14,00 մլն
11,00 մլն
11,00 մլն
13,00 մլն
Interest expense
-107,00 մլն
-109,00 մլն
-106,00 մլն
-103,00 մլն
Net interest expenses
-93,00 մլն
-98,00 մլն
-95,00 մլն
-90,00 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
867,00 մլն
713,00 մլն
988,00 մլն
913,00 մլն
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google Apps